Regeneron implemented these new temporary terms April 1. These terms apply retroactively for Eylea (vial or prefilled syringe) purchased on or after March 1, 2020. The temporary payment terms are subject to change and will be evaluated as the COVID-19 situation evolves.
Genentech said it will temporarily extend physician payment terms for Lucentis purchases from 60 days to 120 days, according to a company news release. Purchases from April 1, 2020, as well as retroactively for purchases made on or after March 1, 2020, will be eligible for the extension. Physicians should contact their respective specialty distributor with questions or to verify the new terms, the company said in a news release.